Stockscreener 앱 받기
1.66
9.78%
-0.18
시간 외 거래:
1.69
0.03
+1.81%
전일 마감가:
$1.84
열려 있는:
$1.81
하루 거래량:
973.73K
Relative Volume:
1.46
시가총액:
$59.67M
수익:
$210.70K
순이익/손실:
$-21.37M
주가수익비율:
-1.5091
EPS:
-1.1
순현금흐름:
$-21.10M
1주 성능:
-13.54%
1개월 성능:
-13.54%
6개월 성능:
-19.42%
1년 성능:
-19.81%
1일 변동 폭
$1.66
$1.81
1주일 범위
$1.66
$2.04
52주 변동 폭
$1.41
$2.81
게인 테라퓨틱스 Stock (GANX) Company Profile
명칭
Gain Therapeutics Inc
전화
(301) 500-1556
주소
4800 HAMPDEN LANE, BETHESDA
GANX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.66 | 66.15M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
게인 테라퓨틱스 Stock (GANX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-12-06 | 개시 | ROTH MKM | Buy |
| 2024-08-14 | 재개 | Oppenheimer | Outperform |
| 2021-04-12 | 개시 | BTIG Research | Buy |
| 2021-04-12 | 개시 | Oppenheimer | Outperform |
게인 테라퓨틱스 주식(GANX)의 최신 뉴스
Why Gain Therapeutics Inc. stock remains on buy listsPortfolio Growth Summary & Smart Money Movement Tracker - newser.com
Gain Therapeutics Inc. stock outlook for YEARWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Financial Contrast: ProPhase Labs (NASDAQ:PRPH) versus Gain Therapeutics (NASDAQ:GANX) - Defense World
Building trade automation scripts for Gain Therapeutics Inc.Weekly Stock Report & Safe Swing Trade Setups - newser.com
Sentiment analysis tools applied to Gain Therapeutics Inc.Trend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Is Gain Therapeutics Inc. stock entering bullish territory2025 Market Trends & High Accuracy Swing Entry Alerts - newser.com
Take off with Gain Therapeutics Inc (GANX): Get ready for trading - setenews.com
Is Gain Therapeutics Inc. stock ready for a breakoutSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Will Gain Therapeutics Inc. stock go up soonQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
Advanced analytics toolkit walkthrough for Gain Therapeutics Inc.2025 Pullback Review & Daily Stock Trend Reports - newser.com
Using R and stats models for Gain Therapeutics Inc. forecastingTrade Entry Report & Weekly Stock Breakout Alerts - newser.com
Gain Therapeutics Inc. stock trend outlook and recovery pathPortfolio Gains Summary & Daily Price Action Insights - newser.com
Is Gain Therapeutics Inc. stock undervalued vs historical averages2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Is Gain Therapeutics Inc. stock a dividend growth opportunity2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com
Is Gain Therapeutics Inc. stock a buy before product launchesQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Using Python tools to backtest Gain Therapeutics Inc. strategies2025 Sector Review & Low Risk High Win Rate Picks - newser.com
How risky is Gain Therapeutics Inc. stock now2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - newser.com
Can machine learning forecast Gain Therapeutics Inc. recoveryTrade Ideas & Long Hold Capital Preservation Tips - newser.com
Can Gain Therapeutics Inc. stock deliver sustainable ROETrade Volume Report & Weekly Setup with ROI Potential - newser.com
Will Gain Therapeutics Inc. stock deliver strong dividend growthJuly 2025 Levels & Smart Allocation Stock Tips - newser.com
Gain Therapeutics Advances Parkinson’s Treatment with GT-02287 Study - MSN
Gain Therapeutics, Inc. (NASDAQ:GANX) Short Interest Up 200.7% in October - MarketBeat
Gain Therapeutics, Inc. (GANX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Gain Therapeutics to Present at Neuroscience 2025 - The Manila Times
Gain Therapeutics (NASDAQ: GANX) to present GT-02287 poster at Society for Neuroscience - Stock Titan
What technical charts say about Gain Therapeutics Inc. stock2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
게인 테라퓨틱스 (GANX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):